3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
4
Non-Muscle Invasive Bladder Neoplasms
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Rhabdoid Tumor
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Interventions
Carboplatin
52
pembrolizumab
51
Pemetrexed
44
Cisplatin
35
Paclitaxel
21
Nivolumab
20
Docetaxel
19
durvalumab
17
Gemcitabine
14
130-nm albumin-bound paclitaxel
14
osimertinib
13
Cetuximab
12
Specimen Handling
11
Magnetic Resonance Spectroscopy
11
atezolizumab
10
amivantamab
8
Taxes
7
Radiotherapy
7
lazertinib
6
alectinib
6
Ramucirumab
6
Radiosurgery
6
Observation
6
Ipilimumab
6
Bevacizumab
6
cemiplimab
5
Leucovorin
5
Fluorouracil
5
zimberelimab
4
entrectinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
erdafitinib
×
30 days
×
Clear all
No trials found.